Joao Pedras-Vasconcelos
FDA investigator
Appears on 1 document from 2021, mostly at sites in California. Most often cites responsibilities of quality control unit (21 CFR 211.22).
- 1
- Documents on file
- 5.0
- Observations per 483
- 2021
- First seen
- 2021
- Most recent
What they cite most
From 5 observations- 21 CFR 211.22Responsibilities of quality control unit2
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.103Calculation of yield1
- 21 CFR 211.160General requirements1
Activity by year
2021: 1
Where
California 1
Often inspects with
Is Joao Pedras-Vasconcelos coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2021-10-12 | 483 Revance Therapeutics, IncOct 12, 2021 · Newark, California | Newark, California | 5 |
About this profile
What does Joao Pedras-Vasconcelos inspect?
Joao Pedras-Vasconcelos appears on 1 document on file covering 1 site, mostly in California.
What do they cite most often?
21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.100 and 21 CFR 211.103.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Joao Pedras-Vasconcelos is dated Oct 12, 2021.